ReviewRadiofrequency Catheter Ablation For Atrial Fibrillation: Approaches And Outcomes
Introduction
The focus of treatment in patients with atrial fibrillation (AF) centres on assessment and reduction of thromboembolic events by anti-coagulation and the treatment of symptoms. Anti-arrhythmic drug therapy had, for many years, been the cornerstone of therapy in paroxysmal AF. However, the long-term efficacy of medical management in this setting is sub-optimal and often unsatisfactory due to recurrent episodes of AF and side effects [1]. Over the last decade, catheter ablation has evolved into a routine procedure for selected patients with AF. This review will focus on recent advances in the understanding of the mechanistic basis of AF and the use of catheter ablation in its treatment.
Section snippets
Classification of AF
The nomenclature around AF also continues to evolve with the dominant classification being based upon arrhythmia duration and termination. Paroxysmal AF is defined as self-terminating episodes of AF lasting up to seven days. Persistent AF is present when an AF episode either lasts longer than seven days or requires termination by cardioversion with drugs or direct current cardioversion. Long-standing persistent AF is when AF is present for ≥1 year. Permanent AF is defined when a rate control
Medical Therapy for AF
Several randomised trials have failed to show the superiority of anti-arrhythmic medications over simple rate controlling medications in the treatment of AF in terms of mortality, stroke, hospitalisations and quality of life [2], [3], [4]. This has been attributed to an increase in mortality associated with the use of anti-arrhythmic agents [5].
Several randomised studies have shown that catheter ablation is superior to anti-arrhythmic medications in the reduction of symptoms, improved quality
Mechanistic Basis of AF
The last decade has seen significant progress in comprehending the molecular, cellular and electrophysiological basis of AF. Research has focussed on multiple domains, including the role of ion channel remodelling, oxidative stress, altered calcium handling, changes in atrial architecture and connexin expression in the pathogenesis of AF [12]. More recently, novel optical mapping techniques in ex vivo human hearts [13] and high density mapping [14], [15], [16] in patients has also added to our
Indications for AF Ablation
Given the ineffectiveness of medical therapy, the current HRS/EHRA/ECAS/APHRS/SOLAECE Expert Consensus Statement (in press) consider catheter ablation be reserved for patients with atrial fibrillation, which remains symptomatic despite optimal medical therapy, including rate and rhythm control [47]. Table 1 shows the class of consensus indications for catheter ablation for AF, modified from 2017 HRS/EHRA/ECAS/APHRS/SOLAECE Expert Consensus Statement.
Catheter Ablation in Paroxysmal AF
Given that the pulmonary veins are the source of foci initiating paroxysmal AF in 85–95% of patients, PV isolation (PVI) has become the cornerstone of all catheter based AF ablation strategies [48]. This empiric approach does not require detailed assessment of trigger sites, but targets the pulmonary vein antrum to achieve electrical isolation while minimising the risk of pulmonary vein stenosis and phrenic nerve injury. For all PVI techniques, ablation is performed until the endpoint of
Catheter Ablation in Persistent AF
The critical role of pulmonary vein physiology and anatomy has informed an ablation strategy with good long-term outcomes. However, in patients with persistent AF, especially those with long-standing (>12 months) AF, the mechanisms are much less clear. This has led to a wide variety of ablation strategies being published based on differing putative mechanisms. These have universally aimed to add further ablation beyond circumferential pulmonary vein isolation including linear ablation, ablation
Complications of AF Ablation
The published data on catheter ablation for AF report the risk of major complications in the range of 3.9% to 4.5% [77], [78]. These include death (in 1 of 1,000 patients), stroke, cardiac tamponade, atrio-oesophageal fistula, and clinically significant pulmonary vein stenosis. These studies reflect practice in a heterogeneous group of patients and varying ablation strategies between 1999 and 2007. Recent data has demonstrated that the safety profile of this procedure is best within high volume
Future Directions and Challenges
Enduring pulmonary vein isolation remains the major challenge in the setting of paroxysmal AF, with recurrences resulting from reconnections in the majority of cases. Catheters designed to measure tissue contact force have been developed to enable improved lesion creation with a number of studies demonstrating improved success and lower pulmonary vein reconnection [81], [82], [83], [84]. However, a recent multi-centre, randomised study supported previous reports that use of contact force did
Conclusion
Catheter ablation is now an established treatment for patients with symptomatic AF, resulting in significant improvements in quality of life [89]. Success rates in patients with paroxysmal AF and no significant structural heart disease can be in excess of 80%, although multiple procedures may be required. These outcomes are achieved with a very low incidence of complications in high volume centres with experienced operators. For patients with persistent AF, the role of catheter ablation
References (89)
- et al.
Rhythm or rate control in atrial fibrillation–pharmacological intervention in atrial fibrillation (PIAF): A randomised trial
Lancet
(2000) Rhythm management in atrial fibrillation: Less is more
J Am Coll Cardiol
(2003)- et al.
A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: The APAF study
J Am Coll Cardiol
(2006) - et al.
Atrial fibrillation driver mechanisms: Insight from the isolated human heart
Trends Cardiovasc Med
(2017) - et al.
The effect of electrode density on the interpretation of atrial activation patterns in epicardial mapping of human persistent atrial fibrillation
Heart Rhythm
(2016) - et al.
A computer model of atrial fibrillation
Am Heart J
(1964) - et al.
Relationship among complex signals, short cycle length activity, and dominant freque ncy in patients with long-lasting persistent af: A high-density epicardial mapping study in humans
Heart Rhythm
(2011) - et al.
Nerve supply of the human pulmonary veins: An anatomical study
Heart Rhythm
(2009) - et al.
Electrophysiologic and electroanatomic changes in the human atrium associated with age
J Am Coll Cardiol
(2004) - et al.
Electrophysiological, electroanatomical, and structural remodeling of the atria as consequences of sustained obesity
J Am Coll Cardiol
(2015)
Atrial remodeling in varying clinical substrates within beating human hearts: Relevance to atrial fibrillation
Prog Biophys Mol Biol
Atrial remodeling in obstructive sleep apnea: Implications for atrial fibrillation
Heart Rhythm
High-density epicardial mapping of the pulmonary vein-left atrial junction in humans: Insights into mechanisms of pulmonary vein arrhythmogenesis
Heart Rhythm
Treatment of atrial fibrillation by the ablation of localized sources: Confirm (conventional ablation for atrial fibrillation with or without focal impulse and rotor modulation) trial
J Am Coll Cardiol
Focal impulse and rotor modulation: Acute procedural observations and extended clinical follow-up
Heart Rhythm
Catheter ablation of atrial arrhythmias: State of the art
Lancet
Outcomes of long-standing persistent atrial fibrillation ablation: A systematic review
Heart Rhythm
Randomized trial comparing pulmonary vein isolation using the smarttouch catheter with or without real-time contact force data
Heart Rhythm
Circumferential pulmonary vein isolation with the cryoballoon technique results from a prospective 3-center study
J Am Coll Cardiol
Ablation of persistent atrial fibrillation using multielectrode catheters and duty-cycled radiofrequency energy
J Am Coll Cardiol
Cryoballoon temperature predicts acute pulmonary vein isolation
Heart Rhythm
Phrenic nerve injury after atrial fibrillation catheter ablation: Characterization and outcome in a multicenter study
J Am Coll Cardiol
Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: Outcomes from a controlled nonrandomized long-term study
J Am Coll Cardiol
Impact of type of atrial fibrillation and repeat catheter ablation on long-term freedom from atrial fibrillation: Results from a multicenter study
Heart Rhythm
Catheter ablation for atrial fibrillation: Are results maintained at 5 years of follow-up?
J Am Coll Cardiol
Ablation of rotor and focal sources reduces late recurrence of atrial fibrillation compared with trigger ablation alone: Extended follow-up of the CONFIRM trial (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation)
J Am Coll Cardiol
Long-term clinical outcomes of focal impulse and rotor modulation for treatment of atrial fibrillation: A multicenter experience
Heart Rhythm
Early complications of pulmonary vein catheter ablation for atrial fibrillation: A multicenter prospective registry on procedural safety
Heart Rhythm
Complications arising from catheter ablation of atrial fibrillation: Temporal trends and predictors
Heart Rhythm
Pulmonary vein isolation using “contact force” ablation: The effect on dormant conduction and long-term freedom from recurrent atrial fibrillation–a prospective study
Heart Rhythm
Contact force-controlled zero-fluoroscopy catheter ablation of right-sided and left atrial arrhythmia substrates
Heart Rhythm
A novel radiofrequency ablation catheter using contact force sensing: Toccata study
Heart Rhythm
Pulmonary vein isolation using the rhythmia mapping system: Verification of intracardiac signals using the orion mini-basket catheter
Heart Rhythm
Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: The ARREST-AF cohort study
J Am Coll Cardiol
Long-term effect of goal-directed weight management in an atrial fibrillation cohort: A long-term follow-up study (LEGACY)
J Am Coll Cardiol
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: Recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: A report of the heart rhythm society (HRS) task force on catheter and surgical ablation of atrial fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society Of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College Of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society Of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College Of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society Of Thoracic Surgeons, the asia Pacific Heart Rhythm Society, and the Heart Rhythm Society
Heart Rhythm
Amiodarone versus sotalol for atrial fibrillation
N Engl J Med
A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation
N Engl J Med
Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: A randomized trial
JAMA
Catheter ablation treatment in patients with drug-refractory atrial fibrillation: A prospective, multi-centre, randomized, controlled study (catheter ablation for the cure of atrial fibrillation study)
Eur Heart J
Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: A randomized controlled trial
JAMA
Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: Two systematic literature reviews and meta-analyses
Circ Arrhythm Electrophysiol
Efficacy and safety of catheter ablation versus antiarrhythmic drugs for atrial fibrillation: A meta-analysis of randomized trials
J Cardiovasc Med (Hagerstown)
Pathophysiological mechanisms of atrial fibrillation: A translational appraisal
Physiol Rev
Cited by (17)
Radiofrequency catheter ablation of atrial fibrillation: A review of techniques
2023, Trends in Cardiovascular MedicineCitation Excerpt :This is well-established for paroxysmal AF; however, success rates remain disappointing for more advanced forms [9]. This perhaps relates to progression of left atrial disease, such that the pulmonary veins are no longer the sole focus of aberrant electrical signals [10]. Indeed, non-pulmonary vein triggers are frequently found in these patients and are an independent predictor of AF recurrence [11].
A contrastive consistency semi-supervised left atrium segmentation model
2022, Computerized Medical Imaging and GraphicsCitation Excerpt :Patients with AF may have heart palpitations, breathlessness, low energy, and an increased risk of stroke (Center, 2009). Catheter ablation is a current routine therapy for patients with AF (Kalla et al., 2017). However, the success ratio of catheter ablation is unsatisfactory, after which AF recurrence and the second ablation often happen (Chelu et al., 2018).
Epicardial and Endocardial Hybrid Ablation for Atrial Fibrillation
2019, Catheter Ablation of Cardiac ArrhythmiasCardiac computed tomography previous to atrial fibrillation ablation – effects of technological improvements and protocol optimization
2018, Revista Portuguesa de CardiologiaAtrial Fibrillation: State of the Art in 2017 – Shifting Paradigms in Pathogenesis, Diagnosis, Treatment and Prevention
2017, Heart Lung and Circulation